Evidence map›Paper›PMID 33229343›Full record

ArticleThe British journal of ophthalmology2022

Deep learning-based classification and segmentation of retinal cavitations on optical coherence tomography images of macular telangiectasia type 2.

Jessica Loo, Cindy X Cai, John Choong, Emily Y Chew, Martin Friedlander, Glenn J Jaffe, Sina Farsiu

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in The British journal of ophthalmology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01949324 (A Phase 2 Multicenter Randomized Clinical Trial of Ciliary Neurotrophic Factor), which is not on this map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01949324 phase2completednot on this map

A Phase 2 Multicenter Randomized Clinical Trial of Ciliary Neurotrophic Factor (CNTF) for Macular Telangiectasia Type 2 (MacTel)

TypeinterventionalSponsorNeurotech PharmaceuticalsRan2014 to 2017Enrolled67ConditionsMacular Telangiectasia Type 2ArmsCiliary neurotrophic factor (CNTF), Sham procedure, NT-501 Implant, NT-501 Implant procedure
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Jessica LooBiomedical Engineering, Duke University, Durham, North Carolina, USA jessica.loo@duke.edu.ORCID 0000-0002-5484-9339
Cindy X CaiOphthalmology, Duke Medicine, Durham, North Carolina, USA.
John ChoongOphthalmology, Duke Medicine, Durham, North Carolina, USA.
Emily Y ChewEpidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0003-0999-9802
Martin FriedlanderThe Lowy Medical Research Institute, La Jolla, California, USA.
Glenn J JaffeOphthalmology, Duke Medicine, Durham, North Carolina, USA.
Sina FarsiuBiomedical Engineering, Duke University, Durham, North Carolina, USA.ORCID 0000-0003-4872-2902
Duke Medical Center · USDuke University · USNational Institutes of Health · USScripps Research Institute · US

Funding

VISION RESEARCHP30EY005722 · NEI · DUKE UNIVERSITY · PI Vadim Y Arshavsky · 1985 to 2026
$19.3M
ACCORD (Action to Control Cardiovascular Risk in Diabetes)ZIAEY000410 · NEI · NATIONAL EYE INSTITUTE · PI CHEW, EMILY Y · 2009 to 2025
$639k
Phase 2 Clinical Trial of Ciliary Neurotrophic Factor (CNTF) for Macular Telangiectasia Type 2 (MacTel) (14-EI-0078, 17-EI-0136)ZIAEY000536 · NEI · NATIONAL EYE INSTITUTE · PI CHEW, EMILY Y · 2014 to 2025
$635k
MACTEL1ZIAEY000492 · NEI · NATIONAL EYE INSTITUTE · PI CHEW, EMILY Y · 2010 to 2013
$56k
Intramural NIH HHS ZIA EY000410Intramural NIH HHS ZIA EY000492NEI NIH HHS P30 EY005722
6 · The paper itself

Abstract

aimTo develop a fully automatic algorithm to segment retinal cavitations on optical coherence tomography (OCT) images of macular telangiectasia type 2 (MacTel2).

methodsThe dataset consisted of 99 eyes from 67 participants enrolled in an international, multicentre, phase 2 MacTel2 clinical trial (NCT01949324). Each eye was imaged with spectral-domain OCT at three time points over 2 years. Retinal cavitations were manually segmented by a trained Reader and the retinal cavitation volume was calculated. Two convolutional neural networks (CNNs) were developed that operated in sequential stages. In the first stage, CNN1 classified whether a B-scan contained any retinal cavitations. In the second stage, CNN2 segmented the retinal cavitations in a B-scan. We evaluated the performance of the proposed method against alternative methods using several performance metrics and manual segmentations as the gold standard.

resultsThe proposed method was computationally efficient and accurately classified and segmented retinal cavitations on OCT images, with a sensitivity of 0.94, specificity of 0.80 and average Dice similarity coefficient of 0.94±0.07 across all time points. The proposed method produced measurements that were highly correlated with the manual measurements of retinal cavitation volume and change in retinal cavitation volume over time.

conclusionThe proposed method will be useful to help clinicians quantify retinal cavitations, assess changes over time and further investigate the clinical significance of these early structural changes observed in MacTel2.

Indexed as

Deep LearningRetinal TelangiectasisClinical Trials, Phase II as TopicHumansMulticenter Studies as TopicRetinaTomography, Optical Coherenceimagingretina

Identifiers

PMID33229343
PMCPMC8365558
OpenAlexW3108271609

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.